ArticleEuropean journal of pediatrics2026
Investigating vitamin B12 levels in children with obesity: the role of metformin.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo assess vitamin B12 levels in children with obesity and analyze the association with obesity severity, complications and treatment methods.
methodsA retrospective analysis of data of 500 patients with obesity (51.6% boys) was performed, mean age was 13.1 years (range 1.7-17.9), mean BMI Z-score was 2.17 (SD 0.42). Anthropometric data, body composition, blood pressure, lipid profile, glycated hemoglobin and liver enzymes were evaluated. Statistical analysis included Spearman correlation and Mann-Whitney U test (α = 0.05).
resultsDyslipidemia was found in 45.8%, hypertension in 14.8%, elevated liver enzymes in 19.8%. 12% received metformin. Median B12 was 407 pg/ml (range: 161-1168). No correlation was found between B12 and BMI Z-score, body fat percentage, high-density lipoprotein, triglycerides, gamma-glutamyl transferase or glycated hemoglobin. Negative correlation was found with creatinine (p < 0.001) and homeostatic model assessment for insulin resistance (p < 0.001); positive correlation was found with total cholesterol (p = 0.012), low-density lipoprotein (p = 0.029), alanine aminotransferase (p = 0.002) and aspartate aminotransferase (p < 0.001). Metformin users showed significantly lower B12 (398 vs 410 pg/ml, p = 0.043).
conclusionChildren with obesity do not exhibit vitamin B12 deficiency. Obesity severity is not associated with B12 changes. Insulin resistance (especially metformin-treated) may be associated with reduced B12 levels. Pediatric patients with uncomplicated obesity do not require regular vitamin B12 monitoring, whereas it appears necessary in patients on metformin therapy. What is Known - What is New: • The limited literature on vitamin B12 levels in children with obesity reports a negative correlation with obesity severity which is inconsistent with observations from our center performing metabolic assessments on over 500 children with obesity annually. • Our study demonstrates that children with obesity do not exhibit vitamin B12 deficiency and obesity severity is not associated with B12 changes. However, metformin treatment may be associated with reduced B12 levels. • Pediatric patients with uncomplicated obesity do not require regular vitamin B12 monitoring, whereas it appears reasonable in patients on metformin therapy.
Indexed as
Identifiers
41848903What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.